{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:23:24Z","timestamp":1761294204032,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12105-020-01238-9","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T13:02:58Z","timestamp":1603371778000},"page":"588-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4035-452X","authenticated-orcid":false,"given":"Joana A. S.","family":"Marques","sequence":"first","affiliation":[]},{"given":"F\u00e1tima","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Daniel P.","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Ricardo P.","family":"Vaz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"issue":"6","key":"1238_CR1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/hed.21022","volume":"31","author":"JS Cooper","year":"2009","unstructured":"Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009;31(6):748\u201358.","journal-title":"Head Neck"},{"issue":"10091","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298\u2013310.","journal-title":"Lancet"},{"issue":"9","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1097\/00005537-200109000-00013","volume":"111","author":"A Urquhart","year":"2001","unstructured":"Urquhart A, Berg R. Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma of the head and neck. Laryngoscope. 2001;111(9):1565\u20139.","journal-title":"Laryngoscope"},{"issue":"1","key":"1238_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amjoto.2014.10.008","volume":"36","author":"JV Bagan","year":"2015","unstructured":"Bagan JV, Carbonell F, Gomez MJ, et al. Extra-nodal B-cell non-Hodgkin\u2019s lymphomas of the head and neck: a study of 68 cases. Am J Otolaryngol. 2015;36(1):57\u201362.","journal-title":"Am J Otolaryngol"},{"issue":"11","key":"1238_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3109\/00016489.2012.694474","volume":"132","author":"H Iguchi","year":"2012","unstructured":"Iguchi H, Wada T, Matsushita N, Oishi M, Yamane H. Anatomic distribution of hematolymphoid malignancies in the head and neck: 7 years of experience with 122 patients in a single institution. Acta Otolaryngol. 2012;132(11):1224\u201331.","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"1238_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1052-5149(03)00039-X","volume":"13","author":"AL Weber","year":"2003","unstructured":"Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am. 2003;13(3):371\u201392.","journal-title":"Neuroimaging Clin N Am"},{"issue":"2","key":"1238_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.anorl.2014.07.005","volume":"132","author":"A Picard","year":"2015","unstructured":"Picard A, Cardinne C, Denoux Y, Wagner I, Chabolle F, Bach CA. Extranodal lymphoma of the head and neck: a 67-case series. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132(2):71\u20135.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"10","key":"1238_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00277-010-0970-9","volume":"89","author":"M Mohammadianpanah","year":"2010","unstructured":"Mohammadianpanah M, Daneshbod Y, Ramzi M, et al. Primary tonsillar lymphomas according to the new World Health Organization classification: to report 87 cases and literature review and analysis. Ann Hematol. 2010;89(10):993\u20131001.","journal-title":"Ann Hematol"},{"issue":"20","key":"1238_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"key":"1238_CR10","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89(11):3909\u201318.","DOI":"10.1182\/blood.V89.11.3909"},{"issue":"8","key":"1238_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ajh.24797","volume":"92","author":"JM Vose","year":"2017","unstructured":"Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2017;92(8):806\u201313.","journal-title":"Am J Hematol"},{"issue":"8","key":"1238_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","volume":"12","author":"H Samaha","year":"1998","unstructured":"Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8):1281\u20137.","journal-title":"Leukemia"},{"issue":"1","key":"1238_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29\u201338.","journal-title":"Br J Haematol"},{"issue":"12","key":"1238_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/cncr.22715","volume":"109","author":"A Ferrer","year":"2007","unstructured":"Ferrer A, Salaverria I, Bosch F, et al. Leukemic involvement is a common feature in mantle cell lymphoma. Cancer. 2007;109(12):2473\u201380.","journal-title":"Cancer"},{"issue":"10","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3109\/10428194.2015.1026902","volume":"56","author":"R Shrestha","year":"2015","unstructured":"Shrestha R, Bhatt VR, Guru Murthy GS, Armitage JO. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma. Leuk Lymphoma. 2015;56(10):2759\u201367.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"1238_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3109\/10428194.2015.1094801","volume":"57","author":"VR Bhatt","year":"2016","unstructured":"Bhatt VR, Loberiza FR Jr, Smith LM, et al. Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group experience. Leuk Lymphoma. 2016;57(6):1327\u201334.","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 6","key":"1238_CR17","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/annonc\/7.suppl_6.S35","volume":"7","author":"RI Fisher","year":"1996","unstructured":"Fisher RI. Mantle-cell lymphoma: classification and therapeutic implications. Ann Oncol. 1996;7(Suppl 6):S35\u20139.","journal-title":"Ann Oncol"},{"issue":"3","key":"1238_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","volume":"6","author":"AJ Norton","year":"1995","unstructured":"Norton AJ, Matthews J, Pappa V, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol. 1995;6(3):249\u201356.","journal-title":"Ann Oncol"},{"issue":"4","key":"1238_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0609.2005.00409.x","volume":"74","author":"C Pott","year":"2005","unstructured":"Pott C, Schrader C, Bruggemann M, et al. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease. Eur J Haematol. 2005;74(4):353\u20138.","journal-title":"Eur J Haematol"},{"issue":"11","key":"1238_CR20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","volume":"15","author":"M Bernard","year":"2001","unstructured":"Bernard M, Gressin R, Lefrere F, et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia. 2001;15(11):1785\u201391.","journal-title":"Leukemia"},{"issue":"4","key":"1238_CR21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","volume":"89","author":"G Ott","year":"1997","unstructured":"Ott G, Kalla J, Ott MM, et al. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood. 1997;89(4):1421\u20139.","journal-title":"Blood"},{"issue":"7","key":"1238_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/modpathol.3880144","volume":"13","author":"DS Viswanatha","year":"2000","unstructured":"Viswanatha DS, Foucar K, Berry BR, Gascoyne RD, Evans HL, Leith CP. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol. 2000;13(7):825\u201333.","journal-title":"Mod Pathol"},{"issue":"1","key":"1238_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/annonc\/mdm447","volume":"19","author":"A Ferrer","year":"2008","unstructured":"Ferrer A, Bosch F, Villamor N, et al. Central nervous system involvement in mantle cell lymphoma. Ann Oncol. 2008;19(1):135\u201341.","journal-title":"Ann Oncol"},{"issue":"26","key":"1238_CR24","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/blood-2017-08-737502","volume":"132","author":"M Dreyling","year":"2018","unstructured":"Dreyling M, Klapper W, Rule S. Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge! Blood. 2018;132(26):2722\u20139. https:\/\/doi.org\/10.1182\/blood-2017-08-737502.","journal-title":"Blood"},{"key":"1238_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1309\/U98ADVKUC26R2RJA","volume":"119","author":"HY Dong","year":"2003","unstructured":"Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 2003;119:218\u201330.","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"1238_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12663-012-0383-5","volume":"14","author":"K Rajkumar","year":"2015","unstructured":"Rajkumar K, Rao R, Chawla N, Bandyopadhyay TK, Sinha R. Mantle cell lymphoma of the oral cavity with multiple foci: a case report and review of the literature. J Maxillofac Oral Surg. 2015;14(Suppl 1):138\u201344.","journal-title":"J Maxillofac Oral Surg"},{"issue":"3","key":"1238_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.clon.2003.10.010","volume":"16","author":"S Hart","year":"2004","unstructured":"Hart S, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW. Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971\u20132000). Clin Oncol (R Coll Radiol). 2004;16(3):186\u201392.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1017\/S0022215100142288","volume":"112","author":"NS Aguilera","year":"1998","unstructured":"Aguilera NS, Uusafr M, Wenig BM, Abbondanzo SL. The blastic variant of mantle cell lymphoma arising in Waldeyer\u2019s tonsillar ring. J Laryngol Otol. 1998;112(10):991\u20134.","journal-title":"J Laryngol Otol"},{"issue":"15","key":"1238_CR29","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/cncr.30068","volume":"122","author":"JB Cohen","year":"2016","unstructured":"Cohen JB, Han X, Jemal A, Ward EM, Flowers CR. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma. Cancer. 2016;122(15):2356\u201363.","journal-title":"Cancer"},{"issue":"10","key":"1238_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa1412096","volume":"372","author":"T Robak","year":"2015","unstructured":"Robak T, Huang H, Jin J, et al. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med. 2015;372(10):944\u201353.","journal-title":"N Engl J Med"},{"issue":"19","key":"1238_CR31","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1182\/blood-2013-11-531327","volume":"123","author":"IW Flinn","year":"2014","unstructured":"Flinn IW, van der Jagt R, Kahl BS, et al. Randomized trial of bendamustine-rituximab or R-CHOP\/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood. 2014;123(19):2944\u201352.","journal-title":"Blood"},{"issue":"2","key":"1238_CR32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2010.08228.x","volume":"150","author":"JE Romaguera","year":"2010","unstructured":"Romaguera JE, Fayad LE, Feng L, et al. Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate\/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma. Br J Haematol. 2010;150(2):200\u20138.","journal-title":"Br J Haematol"},{"issue":"3","key":"1238_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","volume":"158","author":"CH Geisler","year":"2012","unstructured":"Geisler CH, Kolstad A, Laurell A, et al. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol. 2012;158(3):355\u201362.","journal-title":"Br J Haematol"},{"issue":"19","key":"1238_CR34","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1505237","volume":"373","author":"J Ruan","year":"2015","unstructured":"Ruan J, Martin P, Shah B, et al. Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma. N Engl J Med. 2015;373(19):1835\u201344.","journal-title":"N Engl J Med"},{"issue":"2","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1182\/blood-2014-08-597914","volume":"125","author":"K Maddocks","year":"2015","unstructured":"Maddocks K, Christian B, Jaglowski S, et al. A phase 1\/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed\/refractory non-Hodgkin lymphoma. Blood. 2015;125(2):242\u20138.","journal-title":"Blood"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-020-01238-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T22:49:11Z","timestamp":1698274151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-020-01238-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1007\/s12105-020-01238-9","relation":{},"ISSN":["1936-0568"],"issn-type":[{"type":"electronic","value":"1936-0568"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}